Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Nature Communications|April 21, 2023
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymomaKonstantin Okonechnikov, Aylin Camgöz, Owen Chapman, et al.Nature Genetics|November 9, 2023
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastomaOwen S Chapman, Jens Luebeck, Sunita Sridhar, et al.Cancer Cell|March 1, 2016
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesPascal D Johann, Serap Erkek, Marc Zapatka, et al.Biorxiv : the Preprint Server for Biology|August 7, 2023
Systematic assessment of long-read RNA-seq methods for transcript identification and quantificationFrancisco J Pardo-Palacios, Dingjie Wang, Fairlie Reese, et al.Nature|June 8, 2018
Author Correction: The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.Nature|March 1, 2018
The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.Nature Methods|June 7, 2024
Systematic assessment of long-read RNA-seq methods for transcript identification and quantificationFrancisco J Pardo-Palacios, Dingjie Wang, Fairlie Reese, et al.Nature|July 21, 2017
The whole-genome landscape of medulloblastoma subtypesPaul A Northcott, Ivo Buchhalter, A Sorana Morrissy, et al.The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.Pageof 11